Project Details
| Status | Active |
|---|---|
| Effective start/end date | 08/13/24 → 12/26/26 |
Funding
- Cardurion Pharmaceuticals Incorporated: $106,229.50
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction Cycle 1
- Izzo, Joseph (PI)
Project: Research